← ANALYST RATINGS · TIPRANKS
Simulations Plus (SLP): analyst forecast and price target
Analyst consensus
0 Buy0 Hold0 Sell
Ratings of 0 analysts in the last 3 months · top analysts only12-month forecast
Based on 0 price targets given in the last 3 months, the average target is —, the highest —, the lowest —. The average is — from the last price of $18.50.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Software - ApplicationxAI Grok-3 | TipRanks - xAI | $21.00 | Buy | +13.5% | Reiterated | 29.08.26on TipRanks Aug 28 23:05 | — | |
| AI DeepSeek Software - ApplicationDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $21.00 | Buy | +13.5% | Reiterated | 29.08.26on TipRanks Aug 28 23:05 | — | |
| AI OpenAI Software - ApplicationOpenAI 5.2 | TipRanks - OpenAI | $20.50 | Buy | +10.8% | Reiterated | 29.08.26on TipRanks Aug 28 23:05 | — | |
| AI Anthropic Software - ApplicationAnthropic Opus-4.5 | TipRanks - Anthropic | $19.00 → $20.00+5.3% | Hold | +8.1% | Reiterated | 29.08.26on TipRanks Aug 28 23:05 | — | |
| AI Google Software - ApplicationGemini 3-pro | TipRanks - Google | $21.00 → $20.50−2.4% | Buy | +10.8% | Reiterated | 29.08.26on TipRanks Aug 28 23:05 | — | |
| AI PerPlexity Software - ApplicationPerPlexity SonarPro | TipRanks - PerPlexity | $21.00 | Buy | +13.5% | Reiterated | 29.08.26on TipRanks Aug 28 23:05 | — | |
| Brendan Smith★★★★★★★★★★#458 · hits 56% · avg +27.3% | TD Cowen | $16.00 | Hold | −13.5% | Reiterated | 09.07.26on TipRanks Jul 10 07:56 | −0.5%next day −1.0% · 5 days −0.5% | ↗ |
| Matt Hewitt★★★★★★★★★★#3011 · hits 47% · avg +4.1% | Craig-Hallum | — | Hold | — | Assigned | 08.07.26on TipRanks 09:10 | +0.3%next day −0.5% · 5 days −1.4% | ↗ |
| Max Smock★★★★★★★★★★#4953 · hits 58% · avg +5.0% | William Blair | — | Hold | — | Downgrade | 17.06.26on TipRanks 04:15 | +1.3%next day −1.1% · 5 days 0.0% | ↗ |
| David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% | BTIG | $18.50 | Hold | 0.0% | Assigned | 16.06.26on TipRanks Jun 17 06:25 | +12.0%next day +1.3% · 5 days +1.6% | ↗ |
| Scott Schoenhaus★★★★★★★★★★#12104 · hits 35% · avg −9.7% | KeyBanc | — | Hold | — | Reiterated | 29.10.25on TipRanks 03:35 | −2.9%next day −2.4% · 5 days −0.6% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $16.00 at a price of $18.43 (−13.2%); now: — at $18.50 (—).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 5 | 5 | 0 | 0 | 0 | 0 |
| Hold | 1 | 3 | 4 | 4 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 28.10.26 (Q4 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.09 (from $0.09 to $0.09). Last quarter: $0.30.
Sales
Next quarter’s sales estimate — $17M (from $17M to $17M). Last quarter: $22M.
Best top-analyst consensus in the sector · Healthcare
About Simulations Plus
- CEO: Shawn O'Connor
- Employees: 213
- 800 Park Offices Drive, Research Triangle Park, NC, 27709, US
- www.simulations-plus.com
Simulations Plus, Inc. (SLP) is a worldwide developer of sophisticated software and services aimed at enhancing drug discovery and development processes. The company employs artificial intelligence and machine learning technologies to create tools for modeling, simulation, and predicting molecular characteristics. Its operations are divided into four main business units: Simulations Plus, Cognigen, DILIsym, and Lixoft. Among its diverse software offerings are GastroPlus, which models the absorption and drug interactions of compounds in both human and animal subjects, as well as DDDPlus and MembranePlus for various simulations. The company also provides a range of products built on mechanistic and mathematical models, such as its quantitative systems pharmacology software like DILIsym, NAFLDsym, IPFsym, RENAsym, and MITOsym. Furthermore, Simulations Plus offers the ADMET Predictor, a chemistry-focused computer program that forecasts molecular properties from structural inputs, alongside MedChem Designer, MonolixSuite, and PKPlus for additional modeling and simulation needs. Beyond software, the company extends its expertise through various services, including contract research for population modeling and simulation, specialized training and consultation to advance pharmacometrics studies, and clinical-pharmacology consulting to aid in regulatory submissions. Simulations Plus serves a broad spectrum of clients globally, including pharmaceutical, biotechnology, agrochemical, cosmetic, and food companies, as well as academic institutions and regulatory bodies. The company was founded in 1996 and maintains its headquarters in Lancaster, California.
Data from the stock’s TipRanks forecast page, read 11225 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗